Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biostar Pharmaceuticals Inc (NASDAQ:BSPM)

1.50
Delayed Data
As of Jun 23
 +0.06 / +4.17%
Today’s Change
1.20
Today|||52-Week Range
7.06
-48.81%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$4.0M

Company Description

BioStar Pharmaceuticals, Inc. enagages in the development, manufacture, and marketing og pharmaceutical and health supplement products for a variety of diseases and conditions. It's products include AoXing Oleanlic Acid capsules, a treatment for Hepatitis B; Hyperthyroidism capsules, Huangyangning tablets, and Taohuasan. The company was founded on March 27, 2007 and is headquartered in Xianyang, China.

Contact Information

BioStar Pharmaceuticals, Inc.
No. 588 Shiji Xi Avenue
Xianyang Shaanxi 712046
P:862933686638
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Rong Hua WangChairman, President & Chief Executive Officer
Zheng Hong WangChief Operating Officer
Xiaojuan ZhaiChief Financial Officer
Gong ShuangSecretary & Administration Director
Qing Hua LiuDirector